human
rhinovirus
hrv
main
caus
coldlik
ill
current
vaccin
antivir
therapi
hrv
avail
prevent
mitig
hrv
infect
antigen
heterogen
hrv
serotyp
hrv
belong
major
group
speci
b
develop
small
anim
model
suscept
infect
major
group
hrv
would
benefici
vaccin
research
previous
show
cotton
rat
sigmodon
hispidu
semipermiss
major
group
speci
hrva
viru
infect
replic
upper
lower
respiratori
tract
measur
patholog
mucu
product
express
inflammatori
mediat
herein
report
intranas
infect
cotton
rat
major
group
speci
hrvb
viru
result
isol
infecti
viru
nose
lung
similar
intramuscular
immun
live
induc
homolog
protect
correl
high
level
serum
neutral
antibodi
vaccin
challeng
experi
evalu
develop
crossprotect
immun
demonstr
intramuscular
immun
live
significantli
protect
anim
challeng
determin
immunolog
mechan
involv
heterolog
protect
character
infect
major
hrv
serotyp
cotton
rat
could
enhanc
robust
model
defin
heterotyp
relationship
divers
group
virus
therebi
increas
potenti
develop
multiserotyp
hrv
vaccin
human
rhinovirus
hrv
singlestrand
positivesens
rna
virus
famili
picornavirida
genu
enteroviru
common
caus
upper
respiratori
tract
urt
infect
worldwid
jacob
et
al
hrv
frequent
detect
associ
hospit
acut
respiratori
ill
young
children
elderli
also
frequent
opportunist
pathogen
transplant
recipi
immunocompromis
patient
kaiser
et
al
milano
et
al
iwan
et
al
kraft
et
al
addit
hrv
infect
associ
exacerb
episod
asthmat
chronic
obstruct
pulmonari
diseas
copd
patient
nicholson
et
al
johnston
et
al
rake
et
al
papi
et
al
consid
high
frequenc
hrv
infect
human
strong
evid
support
role
induc
effector
atopi
asthma
effect
control
hrv
infect
treatment
prevent
would
signific
public
health
benefit
nearli
year
isol
approv
antivir
therapi
prevent
treatment
hrv
infect
jacob
et
al
current
three
genet
distinct
group
hrva
b
c
character
basi
genom
structur
savolainen
et
al
lau
et
al
palmenberg
et
al
simmond
et
al
bochkov
et
al
seventyf
serotyp
hrva
serotyp
hrvb
antigen
distinct
virus
base
crossneutr
properti
vitro
kapikian
et
al
hamparian
et
al
base
competit
cellular
bind
site
two
differ
group
hrv
use
nonident
receptor
cell
attach
defin
approxim
minor
group
serotyp
use
lowdens
lipoprotein
ldl
receptor
cell
entri
hofer
et
al
marlovit
et
al
major
group
serotyp
includ
speci
hrva
speci
hrvb
util
intercellular
adhes
molecul
receptor
greve
et
al
major
group
hrv
also
use
heparin
sulfat
addit
receptor
vlasak
et
al
hrvc
group
virus
infect
convent
cell
line
use
viru
propag
ie
hela
embryon
fibroblast
recent
cadherinrel
famili
member
character
receptor
hrvc
propag
use
revers
genet
facilit
isol
hrvc
strain
bochkov
et
al
bochkov
et
al
addit
hrvc
virus
shown
grow
sinu
mucos
tissu
differenti
sinu
epitheli
cell
bochkov
et
al
ashraf
et
al
effort
vaccin
develop
hinder
hrv
serotyp
extens
antigen
heterogen
broad
circul
savolainen
et
al
lau
et
al
palmenberg
et
al
simmond
et
al
bochkov
et
al
experiment
anim
model
suscept
differ
hrv
serotyp
would
pivot
evalu
degre
crossprotect
vivo
delin
antihrv
vaccin
strategi
conduct
preclin
studi
antivir
compound
sinc
multipl
studi
evalu
mous
model
rhinovirusinduc
diseas
exacerb
allerg
airway
inflamm
bartlett
et
al
mclean
et
al
glanvil
et
al
use
minor
group
serotyp
bartlett
et
al
demonstr
infect
balbc
mous
local
lung
induc
strong
airway
pulmonari
inflamm
mucin
product
albeit
accompani
low
viral
replic
addit
model
major
group
serotyp
infect
also
report
use
transgen
mice
express
humanmous
chimer
receptor
bartlett
et
al
model
show
strong
inflammatori
respons
infect
low
level
viral
replic
similar
balbc
mice
howev
use
transgen
mous
infect
major
group
virus
vivo
crossprotect
studi
could
becom
challeng
therefor
develop
altern
small
anim
model
suscept
infect
major
group
hrv
would
step
forward
vaccin
develop
group
recent
show
intranas
infect
cotton
rat
result
measur
isol
infect
viru
nose
lung
tissu
lower
respiratori
tract
patholog
mucu
product
express
interferon
ifn
activ
gene
without
genet
modif
either
host
viru
blanco
et
al
cotton
rat
anim
model
frequent
use
studi
infect
mani
respiratori
viral
pathogen
affect
human
health
includ
respiratori
syncyti
viru
rsv
boukhvalova
blanco
influenza
ottolini
et
al
blanco
et
al
measl
wyde
et
al
pfeuffer
et
al
recent
reemerg
patel
et
al
previous
demonstr
intramuscular
im
immun
cotton
rat
live
gener
protect
immun
correl
high
level
serum
neutral
antibodi
na
protect
vaccin
anim
well
litter
born
vaccin
femal
challeng
addit
passiv
prophylact
treatment
hyperimmun
serum
protect
anim
challeng
blanco
et
al
result
suggest
cotton
rat
could
becom
use
model
test
vaccin
prophylact
therapi
major
group
hrv
infect
present
studi
extend
capabl
model
report
infect
cotton
rat
anoth
major
group
speci
hrvb
rhinoviru
also
result
isol
infect
viru
nose
lung
tissu
importantli
vaccin
purpos
report
vivo
crossprotect
relationship
previous
describ
result
step
toward
defin
new
level
crossneutr
relationship
among
hrv
shed
new
insight
develop
multiserotyp
hrv
vaccin
four
six
week
old
cotton
rat
obtain
inbr
coloni
maintain
sigmovir
biosystem
inc
sbi
sentinel
cotton
rat
coloni
seroneg
rhinovirus
neutral
assay
seroneg
adventiti
respiratori
virus
eg
pneumonia
viru
mice
rat
parvoviru
rat
coronaviru
sendai
viru
elisa
anim
hous
larg
polycarbon
cage
fed
diet
standard
rodent
chow
water
ad
libitum
anim
work
present
paper
conduct
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
approv
institut
anim
care
use
committe
iacuc
sbi
olaw
assur
cotton
rat
infect
immun
im
either
live
stock
titer
pfuml
stock
titer
pfuml
uvinactiv
isofluran
anesthesia
inocul
viru
prepar
pfu
per
rat
indic
figur
legend
serum
sampl
obtain
retroorbit
blood
collect
isofluran
anesthesia
anim
euthan
carbon
dioxid
asphyxi
infect
work
anim
tissu
cultur
cell
strictli
carri
standard
biosafeti
stock
atcc
cat
atcc
cat
produc
hela
ohio
hela
oh
cell
gener
gift
dr
dean
erdman
cdc
atlanta
ga
unit
state
cell
grown
minim
essenti
medium
contain
earl
salt
emem
fetal
bovin
serum
fb
gl
nahco
lglutamin
penicillinstreptomycin
c
co
viru
stock
prepar
infect
hela
oh
cell
monolay
multipl
infect
approxim
pfucel
infect
cell
maintain
c
harvest
extens
cytopath
effect
cpe
evid
around
h
post
infect
pi
frozen
c
cell
thaw
subject
one
addit
freezethaw
cycl
clarifi
centrifug
rpm
min
supernat
extract
one
volum
watersatur
chloroform
addit
elimin
lipid
moieti
frozen
c
feldman
wang
deutsch
wassermann
infecti
titer
viru
stock
determin
plaqu
assay
monolay
hela
oh
cell
plate
describ
inactiv
prepar
viru
gener
expos
viru
stock
ultraviolet
irradi
min
mjcm
verifi
plaqu
assay
tissu
sampl
left
lung
lobe
entir
nose
homogen
ml
homogen
buffer
emem
fb
gl
nahco
mm
hepe
penicillin
streptomycin
differ
timepoint
pi
infecti
viru
titer
determin
standard
plaqu
assay
express
plaqu
form
unit
pfu
g
tissu
briefli
undilut
tenfold
serial
dilut
tissu
homogen
viru
stock
plate
triplic
onto
confluent
monolay
hela
oh
cell
plate
h
adsorpt
rock
everi
min
monolay
overlay
ml
low
melt
agaros
emem
contain
fb
follow
incub
day
c
monolay
fix
buffer
formaldehyd
stain
crystal
violet
na
titer
determin
either
plaquereduct
assay
figur
cpereduct
assay
figur
plaquereduct
assay
serial
fourfold
dilut
serum
incub
h
c
pfu
viru
incub
pb
use
control
neutral
mix
plate
quadrupl
onto
confluent
hela
oh
cell
monolay
plate
incub
c
h
overlay
low
melt
agaros
emem
contain
fb
cell
incub
c
co
day
fix
buffer
formaldehyd
stain
crystal
violet
quantif
plaqu
cpereduct
assay
cell
atcc
manassa
va
unit
state
seed
plate
attain
confluenc
h
heatinactiv
cotton
rat
sera
twofold
serial
dilut
mix
tcid
either
equal
volum
incub
c
h
one
hundr
serumviru
mixtur
transfer
onto
cell
monolay
plate
duplic
plate
incub
c
co
day
stain
crystal
violet
describ
well
score
presenc
absenc
cpe
plate
noserum
viru
control
includ
number
protect
well
determin
sera
na
titer
assign
basi
highest
dilut
render
protect
monolay
also
use
tcid
input
viru
serumviru
neutral
c
h
katpal
et
al
found
similar
result
rna
isol
lung
lingular
lobe
use
rneasi
kit
qiagen
scienc
cdna
prepar
superscript
r
ii
revers
transcriptas
thermo
fisher
scientif
cdna
reaction
prepar
total
rna
dilut
final
volum
three
cdna
subsequ
use
pcr
reaction
specif
qrtpcr
develop
use
primer
target
region
quantifi
viral
replic
cdna
neg
strand
viral
rna
vrna
indic
activ
rna
transcript
synthes
prime
ttgctagctttaggacctactatatctacctggcctcaat
primer
design
strategi
describ
tag
primer
ad
sequenc
grapevin
viru
tag
end
respect
primer
lim
et
al
realtim
pcr
reaction
perform
use
intern
nest
forward
primer
revers
primer
pcr
amplicon
gener
use
forward
primer
ggcctcaatc
revers
primer
agggtagtg
gelpurifi
sequenc
dilut
gener
copi
number
standard
curv
use
quantifi
rna
vrna
lung
right
lobe
dissect
inflat
neutral
buffer
formalin
normal
volum
immers
formalin
fixat
lung
embed
paraffin
block
section
stain
hematoxylin
eosin
h
e
four
paramet
pulmonari
inflamm
evalu
peribronchiol
perivascul
interstiti
pneumonia
alveol
slide
assess
subject
score
blindli
scale
absent
minim
mild
moder
mark
blanco
et
al
cellular
immun
respons
assess
cotton
rat
specif
elispot
assay
multiscreen
plate
millipor
danver
unit
state
coat
overnight
c
captur
antibodi
goat
anticotton
rat
r
system
inc
minneapoli
mn
unit
state
plate
wash
three
time
pb
contain
pbstween
block
pb
contain
fb
c
h
wash
three
time
pbstween
rins
twice
rpmi
contain
fb
splenocyt
cultur
medium
cotton
rat
splenocyt
duplic
incub
control
cultur
media
well
supernat
uninfect
hela
oh
cell
pfuwel
pfuwel
specif
stimuli
concanavalin
con
reaction
mixtur
volum
follow
h
incub
c
plate
wash
time
pbstween
subsequ
plate
incub
conjug
detect
antibodi
biotinyl
goat
anticotton
rat
r
system
inc
room
temperatur
follow
wash
plate
six
time
pbstween
incub
h
room
temperatur
dilut
streptavidinhorseradish
peroxidas
r
system
inc
plate
wash
five
time
pbstween
pb
plate
develop
readytous
tmb
substrat
elispot
mabtech
cincinnati
oh
unit
state
read
use
autoimmun
diagnostika
multispot
reader
system
aid
gmbh
strassberg
janetzki
et
al
viral
titer
na
titer
vrna
calcul
geometr
mean
standard
error
mean
sem
anim
group
given
time
pi
student
ttest
use
determin
statist
signific
differ
two
group
use
unpair
twotail
test
signific
set
p
figur
c
data
differ
immun
group
assess
oneway
anova
signific
p
individu
differ
identifi
use
bonferroni
post
hoc
test
adult
cotton
rat
infect
pfu
group
three
anim
sacrif
h
pi
anim
inocul
titer
pfu
prior
inactiv
sacrif
h
postinocul
use
neg
control
viral
replic
infecti
viru
recov
nose
h
pi
lung
h
pi
figur
b
respect
replic
viru
detect
anim
infect
euthan
h
pi
inocul
control
anim
h
postinocul
higher
viru
titer
detect
lung
pfug
tissu
compar
nose
pfug
tissu
brief
plateau
viral
load
detect
nose
h
h
pi
lung
follow
clearanc
viru
viral
load
lung
also
quantifi
detect
product
replic
intermedi
vrna
qrtpcr
figur
vrna
strand
detect
lung
infect
anim
h
pi
decreas
dramat
h
pi
figur
anim
inocul
sacrif
h
postinocul
show
undetect
vrna
compar
h
h
figur
next
examin
extent
lung
patholog
follow
infect
earli
h
pi
viru
load
higher
late
h
pi
viru
load
lung
strongli
reduc
figur
infect
show
low
level
cellular
infiltr
mostli
around
bronchiol
within
alveolar
space
h
pi
lead
mild
signific
increas
patholog
compar
anim
inocul
next
investig
effect
im
immun
either
live
infect
gener
serum
na
live
given
im
dose
pfu
day
boost
week
first
immun
anoth
group
cotton
rat
infect
dose
pfu
day
reinfect
week
serum
sampl
collect
anim
boost
reinfect
week
first
immun
infect
na
respons
determin
plaqu
reduct
assay
similar
mockimmun
anim
im
immun
induc
detect
na
titer
figur
contrast
im
immun
live
induc
strong
level
na
titer
week
postimmun
increas
anim
boost
figur
mean
na
titer
log
week
howev
infect
less
effici
induc
na
respons
detect
level
serum
na
one
five
anim
week
pi
reinfect
increas
number
anim
na
total
next
studi
effect
major
group
viru
major
group
b
viru
immun
gener
either
homolog
heterolog
protect
respons
either
viru
demonstr
im
immun
cotton
rat
live
serotyp
gener
strong
na
respons
homolog
viru
figur
blanco
et
al
group
cotton
rat
cotton
rat
immun
boost
im
day
week
respect
group
cotton
rat
immun
boost
im
live
use
homolog
heterolog
viru
challeng
week
first
immun
five
anim
group
euthan
h
pi
determin
lung
viral
titer
figur
consist
previou
data
anim
vaccin
im
live
viru
strongli
protect
homolog
challeng
reduc
lung
viral
titer
least
log
figur
blanco
et
al
importantli
live
im
immun
also
strongli
protect
anim
challeng
homolog
infect
reduc
lung
viral
titer
log
figur
immun
either
render
protect
either
challeng
respect
figur
c
gener
cross
immun
analyz
crosschalleng
experi
cotton
rat
immun
im
live
show
heterolog
protect
challeng
level
pulmonari
viral
replic
figur
howev
im
vaccin
partial
protect
anim
heterolog
challeng
importantli
cotton
rat
vaccin
live
im
infect
log
lower
load
lung
compar
infect
anim
suggest
induct
detect
crossprotect
immun
figur
even
though
crossprotect
immun
observ
vivo
im
immun
anim
detect
na
titer
evid
serum
sampl
im
immun
anim
test
vitro
figur
result
confirm
passiv
transfer
serum
contain
high
titer
na
anim
impart
protect
challeng
figur
furthermor
elispot
assay
observ
increas
number
splenocyt
anim
immun
homolog
stimul
respect
howev
detect
increas
splenocyt
figur
profil
serum
na
im
immun
infect
cotton
rat
use
femal
cotton
rat
mockimmun
im
immun
day
boost
week
first
immun
anoth
group
rat
infect
day
reinfect
week
serum
sampl
obtain
black
symbol
week
red
symbol
first
immun
infect
homolog
serum
na
analyz
sera
assay
duplic
na
titer
express
log
geometr
mean
sem
reciproc
dilut
serum
sampl
achiev
reduct
total
plaqu
p
student
ttest
comparison
week
vs
week
im
immun
infect
group
n
per
group
detect
heterolog
stimul
use
method
figur
group
report
cotton
rat
semipermiss
major
group
similar
extent
previous
develop
transgen
mice
bartlett
et
al
blanco
et
al
show
cotton
rat
suscept
infect
anoth
member
major
group
detect
replic
urt
lower
respiratori
tract
lrt
replic
cycl
shortliv
nose
lung
tissu
cotton
rat
howev
infecti
viru
titer
nose
lung
tissu
measur
h
pi
permit
evalu
vaccin
efficaci
immun
strategi
recent
report
anoth
picornaviru
biolog
similar
hrv
also
exhibit
similar
replic
cycl
cotton
rat
oberst
et
al
patel
et
al
contrast
human
respiratori
virus
eg
rsv
lesser
extent
influenza
viru
show
extend
replic
day
pi
nose
lung
tissu
cotton
rat
ottolini
et
al
blanco
et
al
boukhvalova
blanco
believ
shorter
replic
cycl
hrv
may
repres
hallmark
picornavirus
respiratori
tract
cotton
rat
may
result
differenti
tropism
interferon
suscept
andor
receptor
avail
group
virus
previous
shown
infect
cotton
rat
reproduc
aspect
hrvassoci
human
respiratori
tract
diseas
caus
detect
inflamm
trachea
lower
airway
lung
parenchyma
mucu
product
transient
induct
ifnstimul
gene
blanco
et
al
infect
induc
mild
howev
signific
alveol
bronchiol
perivascul
day
pi
compar
infect
seem
result
milder
inflammatori
respons
reflect
low
level
cellular
infiltr
lung
patholog
figur
result
quit
surpris
howev
hrv
infect
compar
inform
avail
literatur
level
inflamm
lung
patholog
gener
differ
serotyp
similar
im
immun
also
gener
strong
homolog
na
respons
blanco
et
al
figur
infect
reinfect
also
result
induct
moder
na
anim
howev
induc
na
titer
wide
variabl
within
group
compar
im
group
previous
observ
singl
infect
induc
detect
na
respons
blanco
et
al
similarli
shown
mous
model
two
hrv
infect
necessari
gener
detect
na
mclean
et
al
demonstr
lack
immun
respons
gener
uvinactiv
virus
viral
replic
seem
import
compon
gener
na
cotton
rat
blanco
et
al
figur
possibl
replic
better
lymph
node
drain
im
site
inocul
drain
respiratori
mucosa
agreement
observ
replic
drain
lymph
node
near
site
im
inject
patel
et
al
possibl
explain
reason
higher
na
respons
im
inocul
compar
infect
na
consid
import
protect
hrv
infect
experiment
natur
infect
human
induc
na
provid
protect
reinfect
homolog
hrv
serotyp
barclay
et
al
alper
et
al
inactiv
viru
vaccin
given
im
human
similarli
induc
na
provid
protect
diseas
caus
homolog
hrv
serotyp
doggett
et
al
mitchison
perkin
et
al
buscho
et
al
hamori
et
al
show
live
use
immunogen
administ
im
induc
high
level
protect
homolog
na
correl
abil
virus
undergo
detect
replic
nose
lung
infect
cotton
rat
blanco
et
al
howev
cotton
rat
immun
minor
group
serotyp
use
ldl
receptor
follow
ident
vaccin
schedul
neither
gener
na
replic
effici
urt
lrt
anim
blanco
et
al
addit
anim
fail
render
protect
figur
homolog
heterolog
hrv
protect
measur
vivo
scheme
immun
serum
collect
challeng
experi
anim
either
unimmun
immun
im
immun
im
live
three
week
initi
immun
anim
boost
immunogen
indic
week
half
anim
group
challeng
half
euthan
h
later
determin
lung
viral
titer
lung
viral
titer
follow
b
c
infect
shown
n
animalsgroup
data
repres
two
independ
experi
data
differ
differ
immun
group
infect
assess
oneway
anova
individu
differ
identifi
bonferroni
post
hoc
test
homolog
heterolog
serum
na
titer
sera
na
titer
determin
describ
materi
method
section
sera
assay
duplic
na
titer
express
log
geometr
mean
sem
n
seragroup
na
titer
limit
detect
assay
e
passiv
transfer
hyper
immun
serum
protect
anim
challeng
anim
treat
intraperiton
serum
ml
serum
anim
immun
im
ml
follow
day
anim
challeng
pfu
euthan
h
later
determin
lung
viral
titer
n
per
group
f
elispot
splenocyt
cotton
rat
vitro
stimul
control
media
uninfect
hela
oh
cell
supernat
homolog
heterolog
uvinactiv
virus
con
cotton
rat
either
unimmun
immun
im
live
three
week
initi
immun
anim
boost
immunogen
indic
week
spleen
harvest
produc
cell
estim
elispot
assay
describ
section
materi
method
n
ratsgroup
heterolog
major
group
challeng
blanco
et
al
taken
togeth
data
suggest
first
cotton
rat
might
harbor
conserv
featur
human
counterpart
permit
major
group
hrv
attach
entri
second
data
support
conclus
virus
gener
strong
humor
respons
cotton
rat
upon
im
vaccin
would
potenti
undergo
product
replic
airway
two
characterist
provid
basi
develop
anim
model
major
group
hrv
test
probabl
vaccin
candid
develop
vaccin
formul
vaccin
strategi
hrv
infect
cumbersom
due
antigen
divers
group
virus
glanvil
johnston
clear
vaccin
target
group
virus
need
elicit
immun
respons
broad
enough
protect
wide
rang
hrv
serotyp
key
studi
carri
year
ago
use
sera
rabbit
guinea
pig
immun
differ
hrv
type
cooney
collabor
defin
sever
crossneutr
relationship
hrv
b
type
allow
classif
differ
type
crossreact
group
cooney
et
al
cooney
et
al
recent
genet
cluster
human
serotyp
strain
perform
base
genom
sequenc
region
savolainen
et
al
base
whole
viral
genom
palmenberg
et
al
report
show
immun
recombin
two
distantli
relat
hrv
strain
mice
rabbit
induc
strong
crossna
respons
show
crossprotect
distantli
relat
hrv
strain
howev
crossprotect
evidenc
vitro
neutral
assay
base
previous
publish
serotyp
relationship
edlmayr
et
al
fact
limit
vivo
data
avail
prove
crossprotect
neutral
differ
hrv
data
show
cotton
rat
replic
two
hrv
use
gain
entri
cell
major
group
cotton
rat
partial
protect
major
group
b
challeng
indic
gener
crossserotyp
immun
thu
result
indic
cotton
rat
model
could
use
measur
efficaci
vaccin
homolog
also
could
use
dissect
heterolog
protect
serotyp
major
group
valid
model
deciph
mechan
underli
heterolog
crossprotect
explor
basic
mechan
protect
first
use
vitro
neutral
assay
unabl
detect
crossna
respons
figur
secondli
perform
prophylact
treatment
cotton
rat
use
hyperimmun
pool
serum
blanco
et
al
although
signific
level
na
detect
treat
anim
anim
fail
exhibit
crossprotect
upon
challeng
figur
final
detect
tcell
respons
could
result
crossprotect
seen
vivo
perform
cotton
ratspecif
elispot
assay
use
splenocyt
deriv
anim
stimul
control
cell
supernat
vitro
observ
differ
number
cell
detect
stimul
control
stimul
condit
time
assay
figur
overal
addit
experi
preclud
us
conclud
either
humor
cellular
respons
involv
crossprotect
howev
lay
groundwork
us
carri
focus
investig
airway
lymphocyt
respons
use
bronchoalveolar
lavag
airwaydrain
lymph
node
lung
homogen
sourc
lymphocyt
crossprotect
antibodi
mucos
natur
neutral
vitro
could
suffici
mediat
neutral
vivo
facilit
antibodydepend
cellmedi
cytotox
adcc
present
right
quantiti
distribut
site
infect
glanvil
et
al
addit
elispot
assay
measur
cell
could
also
give
indic
type
respons
gener
crossprotect
report
use
model
hrv
infect
immun
recombin
protein
major
group
combin
promot
adjuv
induc
antigenspecif
respons
airway
enhanc
na
respons
upon
infect
minor
group
viru
major
group
caus
rapid
decreas
lung
viru
load
mice
challeng
indic
immun
capsid
protein
could
prime
anim
develop
broader
crossreact
immun
hrv
mclean
et
al
glanvil
et
al
importantli
glanvil
et
al
shown
splenocyt
protein
immun
mice
produc
stimul
peptid
lack
crossstimul
splenocyt
immun
cotton
rat
stimul
figur
like
result
immun
whole
viru
instead
highli
conserv
peptid
recent
report
shown
serum
na
mani
hrv
induc
polyval
inactiv
hrv
plu
alum
adjuv
use
formul
mice
rhesu
macaqu
lee
et
al
show
extent
hrv
vaccin
immunogen
relat
quantiti
input
antigen
valenc
major
factor
affect
potenc
breadth
respons
addit
shown
na
respons
typespecif
crossneutr
minim
vitro
neutral
activ
induc
vaccin
nonvaccin
type
lee
et
al
addit
fail
document
correl
immunizationmedi
reduct
viral
replic
reduct
lung
patholog
establish
clinic
relev
protect
inflamm
due
primari
infect
mild
present
immun
experi
correl
viral
replic
diseas
could
drawn
howev
result
surpris
sinc
observ
human
cotton
rat
model
also
fail
show
benefit
clinic
outcom
therapeut
administr
antibodi
rsv
infect
use
despit
complet
protect
lung
viral
replic
rodriguez
et
al
malley
et
al
princ
et
al
although
could
demonstr
partial
heterolog
protect
immun
challeng
reciproc
immunolog
relat
two
virus
could
demonstr
figur
c
entir
possibl
immunodomin
epitop
repres
minor
epitop
allow
partial
protect
anim
vaccin
vice
versa
consist
hypothesi
possibl
distinct
immunodomin
epitop
present
elicit
homolog
protect
heterolog
protect
anim
overal
result
step
toward
understand
extent
strength
immunolog
crossrelated
among
hrv
vivo
capac
model
provid
new
insight
develop
multival
hrv
vaccin
requir
incorpor
addit
serotyp
major
group
analysi
deciph
underli
mechan
involv
heterotyp
protect
mcp
jcgb
aek
conceiv
design
experi
wrote
paper
mcp
lmp
aek
carri
experi
analyz
data
msb
snv
contribut
technic
scientif
discuss
